B S Katzenellenbogen - JoVE Visualize

Showing results (111-120 of 168) with videos related to

Pageof 17

Sort By:

The Journal of Biological Chemistry|November 24, 1999

Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. caveolin-1 drives ligand-independent nuclear translocation and activation of ERalphaA Schlegel, C Wang, B S Katzenellenbogen, et al.

Endocrinology|October 30, 1998

Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimerasE M McInerney, K E Weis, J Sun, et al.

Biochemistry|December 16, 1997

Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interactionK E Carlson, I Choi, A Gee, et al.

Biochemistry|May 13, 1997

17 alpha (haloacetamidoalkyl) estradiols alkylate the human estrogen receptor at cysteine residues 417 and 530S Aliau, D El Garrouj, A Yasri, et al.

Molecular Endocrinology (Baltimore, Md.)|August 1, 1997

Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changesG Lazennec, T R Ediger, L N Petz, et al.

Molecular Endocrinology (Baltimore, Md.)|March 27, 2001

Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogenS Wissink, B van der Burg, B S Katzenellenbogen, et al.

The Journal of Biological Chemistry|July 5, 1993

Powerful dominant negative mutants of the human estrogen receptorB A Ince, Y Zhuang, C K Wrenn, et al.

Journal of Medicinal Chemistry|July 8, 1999

Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenesM J Meyers, J Sun, K E Carlson, et al.

Journal of Medicinal Chemistry|December 1, 1979

Antiestrogens and antiestrogen metabolites: preparation of tritium-labeled (+/-)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxyl]-1,2-propanediol (U-23469) and characterization and synthesis of a biologically important metaboliteT Tatee, K E Carlson, J A Katzenellenbogen, et al.

Breast Cancer Research and Treatment|May 1, 1997

William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancerB S Katzenellenbogen, M M Montano, K Ekena, et al.

Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:

Pageof 17

The Journal of Biological Chemistry|November 24, 1999

Caveolin-1 potentiates estrogen receptor alpha (ERalpha) signaling. caveolin-1 drives ligand-independent nuclear translocation and activation of ERalphaA Schlegel, C Wang, B S Katzenellenbogen, et al.

Endocrinology|October 30, 1998

Transcription activation by the human estrogen receptor subtype beta (ER beta) studied with ER beta and ER alpha receptor chimerasE M McInerney, K E Weis, J Sun, et al.

Biochemistry|December 16, 1997

Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interactionK E Carlson, I Choi, A Gee, et al.

Biochemistry|May 13, 1997

17 alpha (haloacetamidoalkyl) estradiols alkylate the human estrogen receptor at cysteine residues 417 and 530S Aliau, D El Garrouj, A Yasri, et al.

Molecular Endocrinology (Baltimore, Md.)|August 1, 1997

Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changesG Lazennec, T R Ediger, L N Petz, et al.

Molecular Endocrinology (Baltimore, Md.)|March 27, 2001

Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogenS Wissink, B van der Burg, B S Katzenellenbogen, et al.

The Journal of Biological Chemistry|July 5, 1993

Powerful dominant negative mutants of the human estrogen receptorB A Ince, Y Zhuang, C K Wrenn, et al.

Journal of Medicinal Chemistry|July 8, 1999

Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenesM J Meyers, J Sun, K E Carlson, et al.

Journal of Medicinal Chemistry|December 1, 1979

Antiestrogens and antiestrogen metabolites: preparation of tritium-labeled (+/-)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxyl]-1,2-propanediol (U-23469) and characterization and synthesis of a biologically important metaboliteT Tatee, K E Carlson, J A Katzenellenbogen, et al.

Breast Cancer Research and Treatment|May 1, 1997

William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancerB S Katzenellenbogen, M M Montano, K Ekena, et al.

Pageof 17